Synapse - Amber Courtney King

Amber Courtney King

Man

Research Focus

Pharmacy; Clinical Pharmacy Specialist

Recent additions – View all

Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia
Journal Article

King, A. C.; Pappacena, J. J.; Tallman, M. S.; Park, J. H.; Geyer, M. B.
Leukemia Research (2019)

Fulltext@MSK | Save
Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia
Meeting Abstract

King, A. C.; Pappacena, J.; Tallman, M. S.; Park, J. H.; Geyer, M. B.
Blood (2018)

Fulltext@MSK | Save
Ruxolitinib in combination with dasatinib and dexamethasone is an active and well-tolerated chemotherapy-sparing oral induction regimen for adults with Philadelphia chromosome-positive ALL: Results of a phase I trial
Meeting Abstract

Geyer, M. B.; Burke, P. W.; King, A. C.; Mauro, M. J.; Tallman, M. S.; Levine, R. L.; Sherr, C. J.; Douer, D.; Park, J. H.
Blood (2018)

Fulltext@MSK | Save

Co-authors at MSK

5

Horvat
5

Park
4

Daley
4

Tallman
3

Buie
3

Geyer
3

Hsu
3

Mauro
2

Douer
2

Pappacena
2

Rampal
1

Berman
1

Cuello
1

Devlin
1

Glass
1

Goldberg
1

Klimek
1

Levine
1

Ogunniyi
1

Pecoraro
1

Peterson
1

Rodriguez
1

Sherr
1

Stein
1

Tang

Types of Work

Publications